Status:
COMPLETED
Outcome of Discharged HFmrEF Patients
Lead Sponsor:
Xiangtan Central Hospital
Conditions:
Heart Failure With Mid Range Ejection Fraction
Eligibility:
All Genders
Brief Summary
This study aimed to define the independent risk factors related cardiac events (cardiac death or heart failure-related hospitalization) among heart failure with mildly reduced ejection fraction (HFmrE...
Detailed Description
This study aimed to define the independent risk factors related cardiac events (cardiac death or heart failure-related hospitalization) among heart failure with mildly reduced ejection fraction (HFmrE...
Eligibility Criteria
Inclusion
- Diagnosis: Heart failure with mildly reduced ejection fraction (HFmrEF) Presence of symptoms and/or signs of HF, and a mildly reduced LVEF (41- 49%); Elevated natriuretic peptides (BNP \>35 pg/mL or NT-proBNP \>125 pg/mL); Other evidence of structural heart disease.
Exclusion
- none
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
1693 Patients enrolled
Trial Details
Trial ID
NCT05240118
Start Date
January 1 2015
End Date
August 31 2021
Last Update
February 15 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.